[Some issues in the diagnosis and treatment of hyperprolactinemia].
作者信息
Jin Zi-Meng
出版信息
Zhonghua Fu Chan Ke Za Zhi. 2008 Apr;43(4):241-3.
PMID:18843959
Abstract
摘要
相似文献
1
[Some issues in the diagnosis and treatment of hyperprolactinemia].
Zhonghua Fu Chan Ke Za Zhi. 2008 Apr;43(4):241-3.
2
Hyperprolactinemia and prolactinomas.
Endocrinol Metab Clin North Am. 2008 Mar;37(1):67-99, viii. doi: 10.1016/j.ecl.2007.10.013.
3
A prolactinoma masked by a herbal remedy.
Eur J Obstet Gynecol Reprod Biol. 2008 Apr;137(2):257-8. doi: 10.1016/j.ejogrb.2006.12.020. Epub 2007 Feb 12.
4
Hyperprolactinemia; etiology, diagnosis and treatment alternatives.
Acta Obstet Gynecol Scand. 1998 Mar;77(3):249-62.
5
Update on prolactinomas. Part 2: Treatment and management strategies.
J Clin Neurosci. 2015 Oct;22(10):1568-74. doi: 10.1016/j.jocn.2015.03.059. Epub 2015 Aug 1.
6
The hook effect in prolactin immunoassays.
Saudi Med J. 2004 May;25(5):656-9.
7
Hyperprolactinemia and prolactinoma.
Handb Clin Neurol. 2014;124:185-95. doi: 10.1016/B978-0-444-59602-4.00013-7.
8
Hyperprolactinemia in children: clinical features and long-term results.
J Pediatr Endocrinol Metab. 2012;25(11-12):1123-8. doi: 10.1515/jpem-2012-0130.
9
Prolactin-secreting tumors: what's new?
Expert Rev Anticancer Ther. 2006 Sep;6 Suppl 9:S29-35. doi: 10.1586/14737140.6.9s.S29.
10
Controversial issues in the management of hyperprolactinemia and prolactinomas - An overview by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism.
Arch Endocrinol Metab. 2018 Mar-Apr;62(2):236-263. doi: 10.20945/2359-3997000000032.
Zotero 插件